Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Doximity (DOCS)
NYSE:DOCS
Holding DOCS?
Track your performance easily
DOCS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$22.96 - $61.75
Previous Close$57.83
Volume7.96M
Average Volume (3M)1.94M
Market Cap
$10.80B
Enterprise Value$10.00B
Total Cash (Recent Filing)$805.56M
Total Debt (Recent Filing)$13.49M
Price to Earnings (P/E)66.5
Beta1.93
Next Earnings
Feb 06, 2025EPS Estimate
$0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.87
Shares Outstanding186,691,761
10 Day Avg. Volume1,908,009
30 Day Avg. Volume1,941,142
Standard Deviation0.18
R-Squared0.15
Alpha-0.00091
Financial Highlights & Ratios
PEG Ratio1.42
Price to Book (P/B)11.23
Price to Sales (P/S)20.89
Price to Cash Flow (P/CF)39.50
P/FCF Ratio40.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue19.36
Enterprise Value/Gross Profit23.55
Enterprise Value/Ebitda43.18
Forecast
1Y Price Target
$57.50Price Target Upside-0.57% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering16
Doximity News
Bulls Say, Bears Say
Bulls Say
Market Position And Growth ProspectsDoximity is viewed as one of the leading companies in the healthcare provider advertising space, having strong relationships with pharmaceutical companies.
Revenue Growth PotentialDoximity generates digital ad revenue from only ~50-55% of all pharmaceutical brands that are currently generating >$100M in annual U.S. product sales, giving Doximity a long runway for additional revenue opportunity.
User Engagement And PartnershipsHeavy user engagement on the app has allowed Doximity to attract ~100+ biopharma companies to spend at least $500k annually on digital pharma marketing spend.
Bears Say
Marketing SpendPotential slowdown in marketing spend among biopharma companies toward prescribing physicians and healthcare professionals could impact growth.
Revenue GuidanceThe implied 4Q guidance suggests a notable decline in revenue growth and adjusted EBITDA margin, raising concerns about the sustainability of current growth rates.
Stock ValuationThe stock's premium multiple does not leave any room for error.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
DOCS FAQ
What was Doximity’s price range in the past 12 months?
Doximity lowest stock price was $22.96 and its highest was $61.75 in the past 12 months.
What is Doximity’s market cap?
Currently, no data Available
When is Doximity’s upcoming earnings report date?
Doximity’s upcoming earnings report date is Feb 06, 2025 which is in 45 days.
How were Doximity’s earnings last quarter?
Doximity released its earnings results on Nov 07, 2024. The company reported $0.3 earnings per share for the quarter, beating the consensus estimate of $0.255 by $0.045.
Is Doximity overvalued?
According to Wall Street analysts Doximity’s price is currently Overvalued.
Does Doximity pay dividends?
Doximity does not currently pay dividends.
What is Doximity’s EPS estimate?
Doximity’s EPS estimate is $0.34.
How many shares outstanding does Doximity have?
Doximity has 128,135,990 shares outstanding.
What happened to Doximity’s price movement after its last earnings report?
Doximity reported an EPS of $0.3 in its last earnings report, beating expectations of $0.255. Following the earnings report the stock price went up 34.155%.
Which hedge fund is a major shareholder of Doximity?
Among the largest hedge funds holding Doximity’s share is Gotham Asset Management LLC. It holds Doximity’s shares valued at 2M.
---
Doximity Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$57.50 (-0.57% Downside)
$57.50 (-0.57% Downside)
Blogger Sentiment
Bullish
DOCS Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 188.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $4.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.1%
Last 30 Days ▲ 17.7%
Last 30 Days ▲ 17.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
112.61%
12-Months-Change
Fundamentals
Return on Equity
19.00%
Trailing 12-Months
Asset Growth
9.06%
Trailing 12-Months
Company Description
Doximity
Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.
---
DOCS Earnings Call
Q2 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call for Doximity showed robust performance with significant revenue growth, improved EBITDA margins, and strong engagement metrics. The success of new products and the client portal contributed positively, although concerns about Q4 revenue growth and stability in the health system business were noted.Read More>---
DOCS Revenue Breakdown
93.00% Subscription
7.00% Other
---
DOCS Stock 12 Month Forecast
Average Price Target
$57.50
▼(-0.57% Downside)
Technical Analysis
Best Analysts Covering DOCS
1 Year
1 Year Success Rate
5/15 ratings generated profit
1 Year Average Return
+14.70%
reiterated a buy rating last month
Copying Vikram Kesavabhotla's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of +14.70% per trade.
---